Home | Contact Us | Log In
(888) 789-6604
Report Stack
Advanced search
Account Detail 0 items in basket
Order History Total $
Saved Searches View Basket basket
Bladder Cancer Global Clinical Trials Review, H1, 2014
Publication Date Mar 2014
Product Type Report
Pages 137
Single User License help $ 2500.00
Site User License help $ 5000.00
Corporate User License help $ 7500.00
 

Reportstack.com does not charge credit card fee, transaction charges, extra tax or VAT on any purchase.

Bladder Cancer Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Bladder Cancer Global Clinical Trials Review, H1, 2014" provides data on the Bladder Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bladder Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bladder Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Bladder Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Bladder Cancer to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Bladder Cancer to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Bladder Cancer 25
Subjects Recruited Over a Period of Time 32
Clinical Trials by Sponsor Type 33
Prominent Sponsors 34
Top Companies Participating in Bladder Cancer Therapeutics Clinical Trials 35
Prominent Drugs 37
Latest Clinical Trials News on Bladder Cancer 38
Jan 13, 2014: Tengion Announces Continued Clinical Progress in Its Neo-Urinary Conduit Program 38
Dec 30, 2013: Heat Biologics Announces Its Phase 1/2 Study of HS-410 in Bladder Cancer Is Open for Enrollment 38
Nov 25, 2013: Heat Biologics Successfully Completes Manufacturing of HS-410 to Start Phase 1/2 Bladder Cancer Trial 39
Jul 16, 2013: OncoGenex Announces Completion of Patient Enrollment in the Borealis-1 Trial of OGX-427 in Metastatic Bladder Cancer 39
Apr 30, 2013: OncoGenex Pharma Initiates Phase II Bladder Cancer Trial Of OGX-427 In Combination With Docetaxel 40
Clinical Trial Profiles 41
Clinical Trial Overview of Top Companies 41
GlaxoSmithKline plc 41
Clinical Trial Overview of GlaxoSmithKline plc 41
Eli Lilly and Company 43
Clinical Trial Overview of Eli Lilly and Company 43
Pfizer Inc. 44
Clinical Trial Overview of Pfizer Inc. 44
Spectrum Pharmaceuticals, Inc. 45
Clinical Trial Overview of Spectrum Pharmaceuticals, Inc. 45
Sanofi 46
Clinical Trial Overview of Sanofi 46
Merck & Co., Inc. 47
Clinical Trial Overview of Merck & Co., Inc. 47
Bayer AG 48
Clinical Trial Overview of Bayer AG 48
F. Hoffmann-La Roche Ltd. 49
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 49
Endo Health Solutions Inc. 50
Clinical Trial Overview of Endo Health Solutions Inc. 50
Bristol-Myers Squibb Company 51
Clinical Trial Overview of Bristol-Myers Squibb Company 51
Clinical Trial Overview of Top Institutes / Government 52
National Cancer Institute 52
Clinical Trial Overview of National Cancer Institute 52
Memorial Sloan Kettering Cancer Center 60
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 60
European Organization for Research and Treatment of Cancer 63
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 63
The University of Texas M. D. Anderson Cancer Center 65
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 65
National Bladder Cancer Collaborative Group 67
Clinical Trial Overview of National Bladder Cancer Collaborative Group 67
Southwest Oncology Group 69
Clinical Trial Overview of Southwest Oncology Group 69
Medical Research Council Clinical Trials Unit 70
Clinical Trial Overview of Medical Research Council Clinical Trials Unit 70
University of Michigan 71
Clinical Trial Overview of University of Michigan 71
Eastern Cooperative Oncology Group 72
Clinical Trial Overview of Eastern Cooperative Oncology Group 72
Medical Research Council 73
Clinical Trial Overview of Medical Research Council 73
Five Key Clinical Profiles 74
Appendix 134
Abbreviations 134
Definitions 134
Research Methodology 135
Secondary Research 135
About GlobalData 136
Contact Us 136
Disclaimer 136
Source 137

List of Tables
List of Tables
Bladder Cancer Therapeutics, Global, Clinical Trials by Region, 2014* 7
Bladder Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Bladder Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Bladder Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Bladder Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Bladder Cancer Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Bladder Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Bladder Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Bladder Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Bladder Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Bladder Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Bladder Cancer to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Bladder Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Bladder Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Bladder Cancer Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Bladder Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Bladder Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Bladder Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Bladder Cancer Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Bladder Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Bladder Cancer Therapeutics, Global, Terminated Clinical Trials, 2014* 27
Bladder Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 32
Bladder Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 33
Bladder Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 34
Bladder Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 36
Bladder Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 37
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 41
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014* 43
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 44
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Spectrum Pharmaceuticals, Inc., 2014* 45
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 46
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 47
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 48
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 49
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Endo Health Solutions Inc., 2014* 50
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014* 51
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 52
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 60
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2014* 63
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014* 65
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Bladder Cancer Collaborative Group, 2014* 67
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Oncology Group, 2014* 69
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical Research Council Clinical Trials Unit, 2014* 70
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2014* 71
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Cooperative Oncology Group, 2014* 72
Bladder Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical Research Council, 2014* 73

List of Figures
List of Figures
Bladder Cancer Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Bladder Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Bladder Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Bladder Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Bladder Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Bladder Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Bladder Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Bladder Cancer Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Bladder Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Bladder Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Bladder Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Bladder Cancer to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Bladder Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Bladder Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Bladder Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Bladder Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Bladder Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Bladder Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 32
Bladder Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 33
Bladder Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 34
Bladder Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 35
Bladder Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 37
GlobalData Methodology 135

Title Date Price
Europe Digital Camera Head for Endoscopes Industry 2016 Market Research Report
By QYResearch
The Europe Digital Camera Head for Endoscopes Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Digital Camera Head for Endoscopes industry. The re ...Read More
Apr 2016 $3600.00
China Pharmaceutical Guidebook Series (4) Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Traditional Chinese Medicines and Natural Medicines
By Access China Management Consulting Ltd
The traditional medicines in Orient, especially, the traditional Chinese medicines are always regarded by occidental as mysterious medicines. Until today not only the chemical composition of tradition ...Read More
May 2015 $750.00
Latest Guide to Chinese Pharmaceutical GMP Regulations
By Access China Management Consulting Ltd
China possesses a fourth population in the world and has one of the largest drug markets round the world. By 2012, sales on the Chinese drug market have reached RMB 926.1billion (about US$147 billion) ...Read More
Jul 2015 $750.00
"Acne vulgaris "- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Acne vulgaris  - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of the disease and ...Read More
Apr 2016 $4950.00
"Acute coronary syndrome(ACS)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Acute coronary syndrome (ACS) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of th ...Read More
Apr 2016 $4950.00
"Acute heart failure(AHF)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Acute heart failure (AHF) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of the di ...Read More
Apr 2016 $4950.00
"Acute ischemic stroke (AIS)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Acute ischemic stroke (AIS) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of the ...Read More
Apr 2016 $4950.00
"Acute lymphoblastic leukemia (ALL)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Acute lymphoblastic leukemia (ALL) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview ...Read More
Apr 2016 $4950.00
"Age-related macular degeneration (AMD)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Age-related macular degeneration (AMD) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overv ...Read More
Apr 2016 $4950.00
"Alzheimer’s disease (AD)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Alzheimer’s disease (AD) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of the d ...Read More
Apr 2016 $4950.00

  * Required field
Name *
E-mail *
Telephone 
Company *
Country *
Query 
 
   

Published By :  GlobalData

For support please
contact:
US Toll Free
+1 888-789-6604
Asia Pacific
+91-9893555190
 
 
To receive alerts about
an update, future offers and discounts on this report, signup here.
Email ID
 

Companies


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Countries


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z